Log In
BCIQ
Print this Print this
 

CNTX-0290

  Manage Alerts
Collapse Summary General Information
Company Centrexion Therapeutics Corp.
DescriptionSomatostatin receptor 4 (SSTR4) agonist
Molecular Target Somatostatin receptor 4 (SSTR4)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsTreat chronic neuropathic, inflammatory and mixed pain
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/30/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today